Capital Analysts, LLC Vaneck ETF Tr Vaneck Pharmaceu Transaction History

Capital Analysts, LLC

$2.45 Billion
Q3 2024

A detailed history of Capital Analysts, LLC transactions in Vaneck ETF Tr Vaneck Pharmaceu stock. As of the latest transaction made, Capital Analysts, LLC holds 232 shares of PPH stock, worth $20,629. This represents 0.0% of its overall portfolio holdings.

Number of Shares

232

Holding current value

$20,629

% of portfolio

0.0%

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2024 Nov 13, 2024	BUY	$90.59 - $99.43 $21,016 - $23,067	232 New	232 $22,000

Others Institutions Holding PPH

# of Institutions

140

Shares Held

5.6M

Call Options Held

12.6K

Put Options Held

7.3K

Goldman Sachs Group Inc New York, NY

2.1M
Shares

$186 Million
0.03% of portfolio
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A6

319K
Shares

$28.4 Million
0.07% of portfolio
Avalon Trust CO Santa Fe, NM

283K
Shares

$25.1 Million
1.99% of portfolio
Thrivent Financial For Lutherans Minneapolis, MN

235K
Shares

$20.9 Million
0.04% of portfolio
Miller Investment Management, LP West Conshohocken, PA

208K
Shares

$18.5 Million
2.06% of portfolio

View Full List

About VANECK ETF TR VANECK PHARMACEU

Ticker PPH
Sector ETFs
Industry ETFs

More about PPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Analysts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Analysts, LLC with notifications on news.

Account

Capital Analysts, LLC Vaneck ETF Tr Vaneck Pharmaceu Transaction History